Innoviva
INVA
#5398
Rank
โ‚ฌ1.38 B
Marketcap
18,75ย โ‚ฌ
Share price
-0.79%
Change (1 day)
12.89%
Change (1 year)

Revenue for Innoviva (INVA)

Revenue in 2026 (TTM): โ‚ฌ0.35 Billion

According to Innoviva's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.36 Billion. In 2025 the company made a revenue of โ‚ฌ0.35 Billion an increase over the revenue in the year 2024 that were of โ‚ฌ0.34 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Innoviva from 2005 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚ฌ0.35 B2.58%
2025 โ‚ฌ0.35 B1.58%
2024 โ‚ฌ0.34 B22.74%
2023 โ‚ฌ0.28 B-9.08%
2022 โ‚ฌ0.30 B-10.73%
2021 โ‚ฌ0.34 B26.37%
2020 โ‚ฌ0.27 B17.52%
2019 โ‚ฌ0.23 B2.13%
2018 โ‚ฌ0.22 B26.03%
2017 โ‚ฌ0.18 B42.57%
2016 โ‚ฌ0.12 B157.36%
2015 โ‚ฌ49.34 M611.59%
2014 โ‚ฌ6.93 M102.49%
2013 โ‚ฌ3.42 M-96.66%
2012 โ‚ฌ0.10 B443.72%
2011 โ‚ฌ18.87 M3.65%
2010 โ‚ฌ18.21 M7.04%
2009 โ‚ฌ17.01 M2.98%
2008 โ‚ฌ16.52 M9.64%
2007 โ‚ฌ15.06 M1.51%
2006 โ‚ฌ14.84 M45.88%
2005 โ‚ฌ10.17 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
OPKO Health
OPK
โ‚ฌ0.50 B 38.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
โ‚ฌ0.19 M-99.95%๐Ÿ‡บ๐Ÿ‡ธ USA